Bavarian Nordic Announces New Major Shareholder from the USA
(Thomson Reuters ONE) -
KVISTGAARD, Denmark, July 13, 2012 - Bavarian Nordic A/S (OMX: BAVA) announced
today that the company has received information that OrbiMed Advisors LLC
indirectly hold more than 5 % of the shares and voting rights in Bavarian Nordic
A/S.
OrbiMed Advisors LLC has informed that they indirectly hold 1,394,829 shares,
corresponding to 5.35 % of the total share capital and voting rights in Bavarian
Nordic A/S.
Asger Aamund
Chairman of the Board
Contact
Anders Hedegaard, President & CEO. Phone +45 23 20 30 64
About Bavarian Nordic
Bavarian Nordic is a vaccine-focused biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline targets cancer
and infectious diseases, and includes ten development programs. In oncology, the
company's lead program is PROSTVAC(®), a therapeutic vaccine candidate for
advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 trial
and is being developed under a collaboration agreement with the National Cancer
Institute. In clinical Phase 1 and Phase 2 trials, PROSTVAC(®) has been tested
in nearly 600 patients. In infectious diseases, the company's lead program is
IMVAMUNE(®), a third-generation smallpox vaccine candidate that is being
developed and supplied for emergency use to the U.S. Strategic National
Stockpile under a contract with the U.S. Government. For more information, visit
www.bavarian-nordic.com
Forward-looking statements
This announcement includes "forward-looking statements" that involve risks,
uncertainties and other factors, many of which are outside of our control that
could cause actual results to differ materially from the results discussed in
the forward-looking statements. Forward-looking statements include statements
concerning our plans, objectives, goals, future events, performance and/or other
information that is not historical information. We undertake no obligation to
publicly update or revise forward-looking statements to reflect subsequent
events or circumstances after the date made, except as required by law.
201210uk:
http://hugin.info/100065/R/1626664/520496.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Bavarian Nordic A/S via Thomson Reuters ONE
[HUG#1626664]
Unternehmensinformation / Kurzprofil:
Datum: 13.07.2012 - 15:25 Uhr
Sprache: Deutsch
News-ID 165128
Anzahl Zeichen: 3026
contact information:
Town:
Kvistgård
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 257 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bavarian Nordic Announces New Major Shareholder from the USA"
steht unter der journalistisch-redaktionellen Verantwortung von
Bavarian Nordic A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
